Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-005455
Filing Date
2015-11-13
Accepted
2015-11-13 17:15:46
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form-10q.htm 10-Q 558255
2 ex31-1.htm EX-31.1 16378
3 ex31-2.htm EX-31.2 16046
4 ex32-1.htm EX-32.1 9643
  Complete submission text file 0001493152-15-005455.txt   3928438

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE trgm-20150930.xml EX-101.INS 722402
6 XBRL SCHEMA FILE trgm-20150930.xsd EX-101.SCH 45969
7 XBRL CALCULATION FILE trgm-20150930_cal.xml EX-101.CAL 50481
8 XBRL DEFINITION FILE trgm-20150930_def.xml EX-101.DEF 158840
9 XBRL LABEL FILE trgm-20150930_lab.xml EX-101.LAB 356742
10 XBRL PRESENTATION FILE trgm-20150930_pre.xml EX-101.PRE 250558
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-Q | Act: 34 | File No.: 000-53071 | Film No.: 151230169
SIC: 2834 Pharmaceutical Preparations